Pharma Journalist - Page 686 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Puma Biotechnology asserts CHMP’s negative opinion on MAA for Neratinib

Pfizer declares update on EMAP for SUTENT in RCC patients

CEL-SCI extends the Expiration Date of Series DD and Series EE Warrants issued

PacBridge Capital Partners (HK) acquires Contextual Genomics

Pfizer sought CHMP Opinion for MYLOTARG and BOSULIF

BioProcess International European Summit: Connecting Science, Technology and Business to Optimise Bioprocessing

AstraZeneca asserts the availability of FLUMIST QUADRIVALENT Vaccine in U.S

NaviGate Cardiac Structures declares GATE bioprosthesis to treat tricuspid regurgitation

Clovis Oncology sought positive vote from CHMP for Rucaparib tablets

Merck forays into acquiring Viralytics augmenting Immuno-Oncology Pipeline